0 results found with selected filters. Please refine the filters. Redirecting to initial search..
How to display a graph
Please select the measurements of same unit in the left filter pane to view the graph.
downloaded on: 2024/09/08 20:20:25
Strain |
Phenotype |
Conditions |
Study |
Experiment Name |
Sex |
Age |
# of Animals |
Value |
Units |
SEM |
SD |
Method |
Method Site |
Method Duration |
Post Insult Time Value |
Record ID |
Study ID |
DA/ZtmRhd |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
14.0 |
d |
0.32 |
1.0 |
in vivo visual assessment |
|
1.296E7 |
0 |
70131 |
1282 |
E3 |
arthritic paw count |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
0.0 |
null |
|
|
in vivo visual assessment |
tail |
1.296E7 |
0 |
70139 |
1282 |
LEW.1F |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
11 |
100.0 |
% |
|
|
in vivo visual assessment |
|
1.296E7 |
0 |
70129 |
1282 |
E3 |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
0.0 |
d |
|
|
in vivo visual assessment |
|
1.296E7 |
0 |
70132 |
1282 |
DA/ZtmRhd |
arthritic paw count |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
3.7 |
null |
0.16 |
0.5 |
in vivo visual assessment |
tail |
1.296E7 |
0 |
70137 |
1282 |
LEW.1F |
subjects with ankylosis to total subjects with arthritis ratio |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
11 |
0.0 |
% |
|
|
in vivo visual assessment |
tail |
1.296E7 |
0 |
70135 |
1282 |
E3 |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
0.0 |
% |
|
|
in vivo visual assessment |
|
1.296E7 |
0 |
70130 |
1282 |
LEW.1F |
post-insult time to onset of experimental arthritis |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
11 |
17.0 |
d |
0.9 |
3.0 |
in vivo visual assessment |
|
1.296E7 |
0 |
70133 |
1282 |
LEW.1F |
arthritic paw count |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
11 |
3.4 |
null |
0.21 |
0.7 |
in vivo visual assessment |
tail |
1.296E7 |
0 |
70138 |
1282 |
E3 |
subjects with ankylosis to total subjects with arthritis ratio |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
0.0 |
% |
|
|
in vivo visual assessment |
tail |
1.296E7 |
0 |
70136 |
1282 |
DA/ZtmRhd |
percentage of study population developing experimental arthritis during a period of time |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
100.0 |
% |
|
|
in vivo visual assessment |
|
1.296E7 |
0 |
70128 |
1282 |
DA/ZtmRhd |
subjects with ankylosis to total subjects with arthritis ratio |
pristane (150 ul) |
Olofsson P, et al., Arthritis Rheum 2002 Jan;46(1):259-68. |
joint integrity trait |
both |
56 days-234 days |
10 |
75.0 |
% |
|
|
in vivo visual assessment |
tail |
1.296E7 |
0 |
70134 |
1282 |
|